Seeing is Believing
Could changes in retinal blood vessels act as an early biomarker for Alzheimer's disease?
Jonathan James | | Longer Read
The connection between retinal physiology and broader brain health has gained significant traction in recent years (1). Demands from clinicians for earlier diagnosis of Alzheimer’s disease has been a clear driver in this regard (2) – but finding new detection modalities has proven both scientifically and clinically challenging. Now, a group of researchers at the Duke University School of Medicine, North Carolina, have shared an approach that is able to differentiate between blood vessel physiology in patients with Alzheimer’s disease, those with mild cognitive impairment, and healthy controls (3).
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!